Neurotrope

NASDAQ:NTRP ISIN:US64129T2078

NeurotropeNeurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer's Disease, Fragile X Syndrome and Niemann-Pick Type C.

  

News

###

413 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 15) (Last 30 Days: 412) (Since Published: 413) 

Company Data

    Headquarters
  • 1185 Avenue of the Americas, 3rd Floor
    New York, NY 10036
    USA
  • Telephone
  • +1-973-242-0005 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.neurotrope.com
  • E:
  • rweinstein@neurotropebioscience.com

Social Media